Health Care Reform: Implementing Comparative Effectiveness Research
The American Recovery and Reinvestment Act of 2009 invested $1.1 billion in federal initiatives to begin the important and necessary work of comparative effectiveness research (CER), a key building block in health care reform. However, whether CER can fulfill expectations of better quality, outcomes and value in health care will depend on how it is implemented.
A forum hosted by the Engelberg Center for Health Care Reform and The Hamilton Project addressed many of the key questions surrounding CER and featured remarks from Sen. Max Baucus (D-Mont.) and Office of Management and Budget Director Peter Orszag. Three discussion papers released at the event focus on how research questions should be prioritized, what methods and data infrastructure are needed for CER, and how CER findings can be used to improve clinical and health policy decisions. A series of distinguished panels discussed the papers’ findings.
Participants took questions after each panel.
Agenda
Getting Our Money's Worth from Patient-Centered Health Research
Dr. Peter Orszag
Director, Congressional Budget Office
Comparative Effectiveness Research: What It Is, What It's Not and Why We Need More
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
David Lansky
President and CEO, Pacific Business Group on Health
Welcome
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
The Future of Comparative Effectiveness Research in the United States
Introductory Remarks
Setting Priorities for Comparative Effectiveness Research (Discussion Paper 1)
Presenter: Alan Garber
Director, Center for Primary Care and Outcomes Research, Stanford School of Medicine
Presenter: David Meltzer
Associate Professor, University of Chicago School of Medicine
Mark Miller
Executive Director - Medicare Payment Advisory Committee
Elizabeth Nabel
Director, National Heart, Lung, and Blood Institute
Harold Sox
Past President, American College of Physicians
Strategies to Improve Comparative Effectiveness Research Methods and Data Infrastructure (Discussion Paper 2)
Robert M. Califf
Duke Translational Medicine Institute
Joshua Ofman
Senior Vice President, Global Value Access & Policy - Amgen
Sebastian Schneeweiss
Harvard Medical School and Brigham and Women’s Hospital
Ellen Sigal
Chairperson and Founder - Friends of Cancer Research
From Better Evidence to Better Care: Using Comparative Effectiveness Research to Guide Practice and Policy (Discussion Paper 3)
Presenter: Steven Pearson
Director, Institute for Clinical and Economic Review
Steven Findlay
Senior Health Policy Analyst, Consumers Union
Marc Berger
Vice President, Global Health Outcomes, Eli Lilly & Co.
Sam Nussbaum
Executive Vice President, Clinical Health Policy and Chief Medical Officer - WellPoint, Inc.
Closing Remarks
Mark B. McClellan
Former Brookings Expert
Director, Margolis Center for Health Policy - Duke University
More Information
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.
